An article published in the Medical Journal of Australia earlier this year points to increased private equity (PE) activity in Australian healthcare, conservatively estimating A$4.5 billion in acquisitions across general practice and selected specialties in 2022 alone. The paper refrains from extensive commentary on the drivers and implications of this trend. However, it points to Continue reading »